220 related articles for article (PubMed ID: 22727957)
1. Thrombospondin-1 mimetic peptide ABT-898 affects neovascularization and survival of human endometriotic lesions in a mouse model.
Nakamura DS; Edwards AK; Virani S; Thomas R; Tayade C
Am J Pathol; 2012 Aug; 181(2):570-82. PubMed ID: 22727957
[TBL] [Abstract][Full Text] [Related]
2. Compatibility of a novel thrombospondin-1 analog with fertility and pregnancy in a xenograft mouse model of endometriosis.
Nakamura DS; Edwards AK; Ahn SH; Thomas R; Tayade C
PLoS One; 2015; 10(3):e0121545. PubMed ID: 25811892
[TBL] [Abstract][Full Text] [Related]
3. Chronic effects of an anti-angiogenic thrombospondin-1 mimetic peptide, ABT-898, on female mouse reproductive outcomes.
Edwards AK; Olariu I; Nakamura DS; Ahn SH; Tayade C
Reprod Biol Endocrinol; 2016 Sep; 14(1):56. PubMed ID: 27604347
[TBL] [Abstract][Full Text] [Related]
4. Animal models for anti-angiogenic therapy in endometriosis.
Edwards AK; Nakamura DS; Virani S; Wessels JM; Tayade C
J Reprod Immunol; 2013 Mar; 97(1):85-94. PubMed ID: 23432875
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis.
Rudzitis-Auth J; Menger MD; Laschke MW
Hum Reprod; 2013 May; 28(5):1339-47. PubMed ID: 23427233
[TBL] [Abstract][Full Text] [Related]
6. Blocking of stromal cell-derived factor-1 reduces neoangiogenesis in human endometriosis lesions in a mouse model.
Virani S; Edwards AK; Thomas R; Childs T; Tayade C
Am J Reprod Immunol; 2013 Nov; 70(5):386-97. PubMed ID: 23650939
[TBL] [Abstract][Full Text] [Related]
7. A peptide inhibitor of synuclein-γ reduces neovascularization of human endometriotic lesions.
Edwards AK; Ramesh S; Singh V; Tayade C
Mol Hum Reprod; 2014 Oct; 20(10):1002-8. PubMed ID: 25024138
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy affects morphology of induced endometriotic lesions in a mouse model through alteration of proliferation and angiogenesis.
Cohen J; Naoura I; Castela M; Von N'Guyen T; Oster M; Fontaine R; Chabbert-Buffet N; Darai E; Aractingi S
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():70-7. PubMed ID: 25461356
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin peptide ABT-898 inhibits inflammation and angiogenesis in a colitis model.
Gutierrez LS; Ling J; Nye D; Papathomas K; Dickinson C
World J Gastroenterol; 2015 May; 21(20):6157-66. PubMed ID: 26034351
[TBL] [Abstract][Full Text] [Related]
10. Natural therapies assessment for the treatment of endometriosis.
Ricci AG; Olivares CN; Bilotas MA; Bastón JI; Singla JJ; Meresman GF; Barañao RI
Hum Reprod; 2013 Jan; 28(1):178-88. PubMed ID: 23081870
[TBL] [Abstract][Full Text] [Related]
11. β-Caryophyllene causes regression of endometrial implants in a rat model of endometriosis without affecting fertility.
Abbas MA; Taha MO; Zihlif MA; Disi AM
Eur J Pharmacol; 2013 Feb; 702(1-3):12-9. PubMed ID: 23353590
[TBL] [Abstract][Full Text] [Related]
12. Crocin improves endometriosis by inhibiting cell proliferation and the release of inflammatory factors.
Liu Y; Qin X; Lu X
Biomed Pharmacother; 2018 Oct; 106():1678-1685. PubMed ID: 30119243
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Hyaluronic Acid Synthesis Suppresses Angiogenesis in Developing Endometriotic Lesions.
Olivares CN; Alaniz LD; Menger MD; Barañao RI; Laschke MW; Meresman GF
PLoS One; 2016; 11(3):e0152302. PubMed ID: 27018976
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities.
Haviv F; Bradley MF; Kalvin DM; Schneider AJ; Davidson DJ; Majest SM; McKay LM; Haskell CJ; Bell RL; Nguyen B; Marsh KC; Surber BW; Uchic JT; Ferrero J; Wang YC; Leal J; Record RD; Hodde J; Badylak SF; Lesniewski RR; Henkin J
J Med Chem; 2005 Apr; 48(8):2838-46. PubMed ID: 15828822
[TBL] [Abstract][Full Text] [Related]
15. The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis.
Delgado-Rosas F; Gómez R; Ferrero H; Gaytan F; Garcia-Velasco J; Simón C; Pellicer A
Reproduction; 2011 Nov; 142(5):745-55. PubMed ID: 21862695
[TBL] [Abstract][Full Text] [Related]
16. The Targeted Delivery of Interleukin 4 Inhibits Development of Endometriotic Lesions in a Mouse Model.
Quattrone F; Sanchez AM; Pannese M; Hemmerle T; Viganò P; Candiani M; Petraglia F; Neri D; Panina-Bordignon P
Reprod Sci; 2015 Sep; 22(9):1143-52. PubMed ID: 25850899
[TBL] [Abstract][Full Text] [Related]
17. Vascular disrupting effects of combretastatin A4 phosphate on murine endometriotic lesions.
Feng D; Menger MD; Laschke MW
Fertil Steril; 2013 Nov; 100(5):1459-67. PubMed ID: 23993929
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo.
Ngô C; Nicco C; Leconte M; Chéreau C; Arkwright S; Vacher-Lavenu MC; Weill B; Chapron C; Batteux F
J Pathol; 2010 Oct; 222(2):148-57. PubMed ID: 20821752
[TBL] [Abstract][Full Text] [Related]
19. Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis.
Arosh JA; Lee J; Balasubbramanian D; Stanley JA; Long CR; Meagher MW; Osteen KG; Bruner-Tran KL; Burghardt RC; Starzinski-Powitz A; Banu SK
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9716-21. PubMed ID: 26199416
[TBL] [Abstract][Full Text] [Related]
20. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis.
Novella-Maestre E; Carda C; Noguera I; Ruiz-Saurí A; García-Velasco JA; Simón C; Pellicer A
Hum Reprod; 2009 May; 24(5):1025-35. PubMed ID: 19189995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]